HNF1B and diabetes mellitus: Although both studies included a similar number of participants and all had HNF1B-associated disease identified secondary to renal disease or diabetes, the median age at inclusion was only 5.5 years (range 0.8–17) compared with 17 years (range 4–65) in our UK cohort.